In our in vitro study, consistent with the inhibitory effects of ebractenoid F on lung cancer cell growth, phosphorylated AKT expression was significantly decreased by ebractenoid F. Moreover, the combination of ebractenoid F and the AKT inhibitor further inhibited lung cancer cell growth and migration and induced apoptosis. This evidence concerns the gene AKT1 and lung carcinoma.